UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~September~~ October 2024

Commission File Number 001-39124

Centogene N.V.
(Translation of registrant's name into English)

Am Strande 7
18055 Rostock

Germany
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Centogene N.V.

OnSupervisory ~~September 25,~~Board 2024, Centogene N.V. issued a press release titled “CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology.” A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.Matters

Centogene N.V. (the “Company”) previously announced the resignation of Peer Schatz, Mary Sheahan and Jonathan Sheldon from the Supervisory Board of the Company (the “Supervisory Board”) effective as of September 30, 2024. Mr. Schatz and Ms. Sheahan have since each notified the Company that they will defer the effective date of their respective resignations from the Supervisory Board to October 15, 2024. The Supervisory Board has approved each such deferral.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: September 25, 2024

Date: October 1, 2024

	CENTOGENE N.V.

	By:	/s/ Peter Bauer
		Name:	Peter Bauer
		Title:	Chief Medical & Genomic Officer

~~CENTOGENE N.V. By: /s/ Jose Miguel Coego Rios Name: Jose Miguel Coego Rios Title: Chief Financial Officer~~3

Exhibit Index

Exhibit Description of Exhibit

99.1 Press release dated September 25, 2024

Filing Compare · Centogene N.V.